Charles Lee
- Genetics top 0.05%
- Genomic variations and chromosomal abnormalities 70
- Genomics and Rare Diseases 32
- Cancer Research top 0.2%
- Cancer Genomics and Diagnostics 17
- Oncology top 0.2%
- Molecular Biology top 0.1%
- Genomics and Phylogenetic Studies 19
- CRISPR and Genetic Engineering 13
- Genomics and Chromatin Dynamics 12
- Pulmonary and Respiratory Medicine top 0.2%
-
- Chromosomal and Genetic Variations 50
-
- Prenatal Screening and Diagnostics 15
- Co-authors
- Stephen W. SchererA. John IafrateLars FeukMark A. RubinPatricia K. DonahoeMiguel N. RiveraYing QiMarc Listewnik
- Cited by
- GeneticsCancer ResearchOncology
- Journals
- Proceedings of the National Academy of Sciences (10 papers)Nature Genetics (9 papers)Blood (6 papers)
- Partner nations
- United StatesSouth KoreaUnited Kingdom
In The Last Decade
Charles Lee
302 papers receiving 27.3k citations
Hit Papers
Peers
Comparison fields: 5 of 202
- Genetics 8.8k
- Cancer Research 4.3k
- Oncology 5.9k
- Molecular Biology 14.6k
- Pulmonary and Respiratory Medicine 5.6k
Countries citing papers authored by Charles Lee
This map shows the geographic impact of Charles Lee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charles Lee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charles Lee more than expected).
Fields of papers citing papers by Charles Lee
This network shows the impact of papers produced by Charles Lee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charles Lee. The network helps show where Charles Lee may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Charles Lee, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Fecal microbiota transplantation improves anti-PD-1 inhibitor efficacy in unresectable or metastatic solid cancers refractory to anti-PD-1 inhibitorbreakdown → | 2024 | 81 |
| 2 | 2024 | 3 | |
| 3 | 2023 | 25 | |
| 4 | 2023 | 2 | |
| 5 | 2022 | 4 | |
| 6 | 2022 | 11 | |
| 7 | 2021 | 10 | |
| 8 | 2019 | 13 | |
| 9 | 2018 | 9 | |
| 10 | 2017 | 12 | |
| 11 | 2017 | 284 | |
| 12 | 2017 | 35 | |
| 13 | 2016 | 62 | |
| 14 | 2013 | 90 | |
| 15 | 2010 | 47 | |
| 16 | MET Amplification Leads to Gefitinib Resistance in Lung Cancer by Activating ERBB3 Signalingbreakdown → | 2007 | 3570 |
| 17 | 2006 | 388 | |
| 18 | Recurrent Fusion of TMPRSS2 and ETS Transcription Factor Genes in Prostate Cancerbreakdown → | 2005 | 2820 |
| 19 | 2005 | 134 | |
| 20 | Yes, Closed-End Fund Discounts Are a Sentiment Index | 1993 | 1 |
About Charles Lee
Charles Lee is a scholar working on Genetics, Virology, Oncology, Molecular Biology and Computational Mathematics, having authored 318 papers that have together received 28.0k indexed citations. Recurring topics across this work include Genomic variations and chromosomal abnormalities (70 papers), Chromosomal and Genetic Variations (50 papers), Genomics and Rare Diseases (32 papers), Genomics and Phylogenetic Studies (19 papers), Cancer Genomics and Diagnostics (17 papers), Prenatal Screening and Diagnostics (15 papers), CRISPR and Genetic Engineering (13 papers) and Genomics and Chromatin Dynamics (12 papers). The work is most often cited by research in Genetics (8.8k citations), Cancer Research (4.3k citations), Oncology (5.9k citations), Molecular Biology (14.6k citations) and Pulmonary and Respiratory Medicine (5.6k citations). Charles Lee has collaborated with scholars based in United States, South Korea and United Kingdom. Frequent co-authors include Stephen W. Scherer, A. John Iafrate, Lars Feuk, Mark A. Rubin, Patricia K. Donahoe, Miguel N. Rivera, Ying Qi, Marc Listewnik, Joëlle Tchinda and George H. Perry. Their work appears in journals such as Proceedings of the National Academy of Sciences, Nature Genetics, Blood, Journal of Virology and Chromosoma.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.